Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Caredx Inc (CDNA)

Caredx Inc (CDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,320,963
  • Shares Outstanding, K 43,784
  • Annual Sales, $ 127,070 K
  • Annual Income, $ -21,970 K
  • 60-Month Beta 0.92
  • Price/Sales 10.82
  • Price/Cash Flow N/A
  • Price/Book 13.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.20
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +10.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.17 +30.47%
on 05/01/20
32.95 -8.25%
on 05/18/20
+4.54 (+17.67%)
since 04/27/20
3-Month
13.04 +131.83%
on 03/18/20
32.95 -8.25%
on 05/18/20
+7.78 (+34.68%)
since 02/27/20
52-Week
13.04 +131.83%
on 03/18/20
41.27 -26.75%
on 07/11/19
-1.40 (-4.43%)
since 05/24/19

Most Recent Stories

More News
CareDx Presents the Latest AlloSure Data in Virtual Meetings

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
CareDx's AlloSeq Tx 17 Awarded CE Mark Approval

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System

CareDx, Inc. (Nasdaq: CDNA) and Veracyte, Inc. (Nasdaq: VCYT) today announced an agreement through which CareDx will become the exclusive worldwide commercialization partner for solid organ transplant-rejection...

CDNA : 30.46 (+0.96%)
VCYT : 25.90 (-3.61%)
CareDx Brings the Transplant Patient Community Together

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
CareDx (CDNA) Reports Break-Even Earnings for Q1

CareDx (CDNA) delivered earnings and revenue surprises of -100.00% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CDNA : 30.46 (+0.96%)
CareDx Reports First Quarter 2020 Results

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
CareDx Engages European Lab Community in Virtual Meetings

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant...

CDNA : 30.46 (+0.96%)
Earnings Preview: CareDx (CDNA) Q1 Earnings Expected to Decline

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDNA : 30.46 (+0.96%)
CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance

CareDx, Inc. (Nasdaq: CDNA) and Johns Hopkins University, announced today the launch of the ALARM (AlloSure Lung Allograft Remote Monitoring) Partnership.

CDNA : 30.46 (+0.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CDNA with:

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

2nd Resistance Point 33.07
1st Resistance Point 31.62
Last Price 30.43
1st Support Level 29.42
2nd Support Level 28.67

See More

52-Week High 41.27
Fibonacci 61.8% 30.49
Last Price 30.43
Fibonacci 50% 27.16
Fibonacci 38.2% 23.82
52-Week Low 13.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar